Astellas Pharma, Inc. (ALPMF)
15.60
+0.08
(+0.48%)
USD |
OTCM |
Apr 24, 16:00
Astellas Pharma EPS Diluted (Quarterly) : 0.3625 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Nxera Pharma Co., Ltd. | -0.5538 |
| PeptiDream Inc. | -0.0267 |
| Stemcell Holdings, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 651.15M |
| Revenue (Quarterly) | 3.707B |
| Total Expenses (Quarterly) | 3.056B |
| Enterprise Value | 30.96B |
| Gross Profit Margin (Quarterly) | 73.89% |
| Profit Margin (Quarterly) | 17.56% |
| Earnings Yield | 7.68% |
| Operating Earnings Yield | 9.66% |
| Normalized Earnings Yield | 7.685 |